Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multiple sclerosis, depression, and the risk of suicide.

Literature DB >> 12221154

Multiple sclerosis, depression, and the risk of suicide.

Eric D Caine, Steven R Schwid.

Abstract

Entities: Disease

Mesh：

Year: 2002 PMID： 12221154 DOI： 10.1212/wnl.59.5.662

Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

1. Relationship between disease-modifying therapy and depression in multiple sclerosis.

Authors: Stephen S Kirzinger; Jason Jones; Angela Siegwald; Andrew Bryce Crush
Journal: Int J MS Care Date: 2013

Review 2. [Quality of life in multiple sclerosis. Measures, relevance, problems, and perspectives].

Authors: W Pöllmann; C Busch; R Voltz
Journal: Nervenarzt Date: 2005-02 Impact factor: 1.214

Review 3. Suicide prevention in neurology patients: evidence to guide practice.

Authors: DeJasna S Lewis; Kathryn Hoehn Anderson; Johanna Feuchtinger
Journal: J Neurosci Nurs Date: 2014-08 Impact factor: 1.230

Review 4. Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression.

Authors: Michele L Pucak; Katherine A L Carroll; Douglas A Kerr; Adam I Kaplin
Journal: Dialogues Clin Neurosci Date: 2007 Impact factor: 5.986

Review 5. Involvement of Innate and Adaptive Immune Systems Alterations in the Pathophysiology and Treatment of Depression.

Authors: Eva M Medina-Rodriguez; Jeffrey A Lowell; Ryan J Worthen; Shariful A Syed; Eléonore Beurel
Journal: Front Neurosci Date: 2018-08-17 Impact factor: 4.677

Multiple sclerosis, depression, and the risk of suicide.

1. Relationship between disease-modifying therapy and depression in multiple sclerosis.

Review 2. [Quality of life in multiple sclerosis. Measures, relevance, problems, and perspectives].

Review 3. Suicide prevention in neurology patients: evidence to guide practice.

Review 4. Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression.

Review 5. Involvement of Innate and Adaptive Immune Systems Alterations in the Pathophysiology and Treatment of Depression.

Review 6. Nuclear receptors modulate inflammasomes in the pathophysiology and treatment of major depressive disorder.

7. Morphostructural MRI abnormalities related to neuropsychiatric disorders associated to multiple sclerosis.

8. Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations.